Bahija Jallal

October 17, 2026

Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends. Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.

October 14, 2026

Immunocore (IMCR) Listed in October Healthcare Watchlist. Immunocore Holdings was included in a Yahoo Finance list of top healthcare stocks to watch in October 2026. This inclusion highlights the company's relevance in the sector, although the stock currently trades near its 52-week low of $27.55. The share price sits close to a key support level at $28.58, while the average analyst target remains significantly higher at $62.73.

October 17, 2026

Guardant Health Wins Patent Ruling, Morgan Stanley Lifts Target. Guardant Health secured a favorable decision from the U.S. Patent Trial and Appeal Board, which rejected a challenge to its core duplex sequencing patent. This legal win supports the company's position in the growing liquid biopsy market. Additionally, Morgan Stanley maintained an Overweight rating and raised its price target to $200, citing strong fundamentals in the diagnostics sector.